| CXSL1900010 | 重组抗血管内皮生长因子（VEGF）单抗注射液 | bevacizumab | Injection | Biological Products(2) | New Drug Application | 2019-02-19 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | In Review | 2019-02-18 | view |
| CXSL1400094 | 重组抗血管内皮生长因子(VEGF)单抗注射液(贝伐单抗) | bevacizumab | Injection | Biological Products(2) | New Drug Application | 2014-11-17 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2016-08-23 | view |
| JXSS1900024 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Import Drug Application | 2019-05-15 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-09-21 | view |
| CXSL2100104 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | New Drug Application | 2021-03-25 | 百奥泰生物制药股份有限公司 | Bio-Thera Solutions Ltd | In Review | 2021-03-24 | view |
| JYSZ2100533 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | License Renew | 2021-12-16 | | | | | view |
| CYSB2300202 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-10-31 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2200052 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2022-02-21 | | Bio-Thera Solutions Ltd | | | view |
| CXSS2000013 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2) | New Drug Application | 2020-04-22 | 山东绿叶制药有限公司 | Shandong Luye Pharmaceutical Co Ltd | In Review | 2020-04-21 | view |
| CYSB2200054 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2022-02-21 | | Bio-Thera Solutions Ltd | | | view |
| JYSB1600045 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2016-04-05 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2016-10-10 | view |
| CYSB2200262 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2022-11-22 | | | | | view |
| CYSB2400103 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-05-01 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JXSL1300020 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Import Drug Application | 2013-04-03 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2015-01-08 | view |
| JYSB2000530 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2020-10-26 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-11-09 | view |
| CYSB2300064 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-03-23 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSS2000046 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | New Drug Application | 2020-09-05 | 东曜药业有限公司 | TOT Biopharm Co Ltd | Certificate Issued | 2021-12-03 | view |
| CYSB2200053 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2022-02-21 | | Bio-Thera Solutions Ltd | | | view |
| CXSS1900004 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2) | New Drug Application | 2019-01-31 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2020-06-22 | view |
| CXSL2101206 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-07-20 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CYSB2100040 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2021-01-25 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | In Review | 2021-01-25 | view |
